During the upcoming UCHAPS membership meeting, participants will discuss the pubic health model for molecular HIV surveillance, debunk myths about molecular surveillance, identify benefits of molecular surveillance, and share best practices in community and government molecular HIV surveillance programs.
On-demand pre-exposure prophylaxis using oral antiretroviral therapy taken by men as little as two hours before engaging in high-risk sex with other men proves more effective in preventing HIV transmission. Join UCHAPS, HealthHIV, and jurisdictions currently running successful same-day PrEP programs for a discussion about same-day PrEP on Thursday, October 26 at 2 PM.
People living with HIV, their partners, healthcare providers and criminal justice system should have accurate information about viral suppression of HIV. Join UCHAPS and featured presenters for a discussion about U=U (Undetectable = Untransmittable) on Friday, October 27 at 2 PM to learn more about the benefits of viral suppression.
CFARs across the United States offer a platform that could help local prevention and treatment goals, especially in informing the planning process, examining opportunities for new insights and direction, and provide certain types of data that could propel HIV prevention and treatment activities. CFARs can also help promote shared goals through mobilization, education and engagement. This panel will explore the various ways CFARs could be a part of local integrated HIV prevention and care activities.
Join UCHAPS and NASTAD to discuss the benefits of e-learning by leveraging online technical assistance platforms as a vehicle for capacity building assistance. You don't want to miss this conversation for health department staff.
UCHAPS knows that PrEP is a valuable tool that women can use to take control of their sexual health and is committed to raising awareness among women about PrEP. Join UCHAPS for a discussion on the unique issues surrounding women and PrEP and representation of women in PrEP research.
During the molecular HIV surveillance webinar, speakers from UCHAPS and the CDC will discuss the public health model for MHS, debunk myths about MHS, and identify benefits of MHS. Presentations will be followed by Q&A with featured speakers and MHS peers.